SecBot SecBot
6-K ·Filed Sep 22, 2026

MBAI

MBody AI Ltd.
BEARISH
Impact 6/10
Horizonweeks Processed1mo ago SEC0001213900-26-102251
Notable filing: 6-K
Actionable Insight ▼ Bearish

Monitor the FY2026 audit for a going concern reassessment of the combined entity, and watch for any shareholder vote to increase authorized share capital or re-designate shares as no-par value, which is critical for future fundraising. The warrant claim filed September 18, 2026 and shareholder derivative litigation could create overhang.

DirectionBearish
Confidencehigh
Horizonweeks
Latest settled — T+20d
MBAI ▼ -59.78% at T+20d
SHORT call ✓ call won +59.78% · α vs SPY +60.47% · entry $5.47 → $2.20
Next anchor: T+60d in 7w
Latest observation: T+22 +56.46% FF3 residual α
Entry = T+0 close
Sep 22, 2026
via day close
T+1d
-17.55%
call +17.55% · α +17.47%
$4.51
settled 5w ago
T+5d
-35.28%
call +35.28% · α +34.61%
$3.54
settled 29d ago
T+20d
-59.78%
call +59.78% · α +60.47%
$2.20
settled 8d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

MBody AI Ltd. filed a 6-K updating its business description and risk factors following the August 26, 2026 merger with MBody AI Corp. The filing discloses extreme customer concentration (MGM and Caesars generate substantially all revenue), a pre-merger going concern warning from Check-Cap Ltd. that has not been reassessed, an illiquid $6.5M equity stake in Apollo, shareholder derivative litigation, a new warrant claim filed September 18, 2026, and a limited authorized share capital (only 2.7M shares remaining) with a nominal value above the trading price. The post-merger entity has no issued patents for its core robotics/AI business and negative operating cash flows despite reported profitability in 2025.

Key Facts

  • Merger closed August 26, 2026; former MBody AI equity holders received ~90% of shares, later diluted to ~80.9% after a $10M public offering at $6.50/share
  • Substantially all revenue comes from two customers: MGM and Caesars
  • Check-Cap Ltd. had a going concern qualification for FY2025; combined company evaluation pending FY2026 audit
  • Equity investment in Apollo valued at $6,525,000 (7.5% stake) is illiquid with no public market
  • Chairman Regan McGee holds ~44.7% of shares and is also CEO/Chairman of Apollo, creating conflicts of interest
  • Shareholder derivative litigation related to Apollo BCA is ongoing; a new warrant claim was filed September 18, 2026
  • Authorized share capital is 18,000,000 shares; 15,293,584 outstanding as of September 21, 2026, leaving only 2,706,416 available
  • Ordinary shares have nominal value of NIS 48.0, above recent trading price, restricting below-par issuances under Israeli law
  • No issued patents for the robotics/AI business; two pending patent applications filed September 15, 2026, neither examined
  • Two provisional patent applications from September 15, 2025 were not converted, losing priority dates
  • MBody AI Corp. achieved profitability in FY2025 but had negative operating cash flow

Financial Impact

Post-merger public offering raised $10.0M gross; equity investment in Apollo carried at $6,525,000; authorized share capital nearly exhausted with only 2.7M shares remaining

revenue concentrationcash positiondilution capacitygoing concern risk

Risk Factors

  • Extreme customer concentration risk — loss of MGM or Caesars would eliminate substantially all revenue
  • Going concern risk not yet reassessed post-merger; negative operating cash flow despite profitability
  • Illiquid $6.5M Apollo equity stake with valuation uncertainty and related-party conflicts
  • Limited authorized shares (2.7M remaining) and nominal value above trading price restrict capital raising flexibility
  • No issued patents for core AI/robotics business; two provisional applications abandoned
  • Ongoing shareholder derivative litigation and new warrant claim

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001213900-26-102251
Document: ea030607601ex99-1.htm0001213900-26-102251
Document: ea0306076-6k_mbody.htm0001213900-26-102251
Document: 0001213900-26-102251-index-headers.html0001213900-26-102251
Document: 0001213900-26-102251-index.html0001213900-26-102251
Document: 0001213900-26-102251.txt0001213900-26-102251
16 reports for MBAI
Performance horizon
100% Hit rate @ T+5 5 of 5 directional calls Went positive at some point 5 of 5 best @ T+20▲ +38.91%Aug 28, 2026
Filters
Rows
Reports for MBAI — sortable, filterable
TypeNow
Oct 22, 2026
5d ago
Press Release
NEUTRAL ★ 4/10
$2.05awaiting T+5—$1.80 (−12.20%)
Sep 29, 2026
28d ago
EFFECT
NEUTRAL ★ 4/10
$3.75 $3.24▼ −13.60%▼ −15.55%$1.80 (−52.00%)
Sep 22, 2026
4w ago
SC 13D
NEUTRAL ★ 4/10
$5.47 $3.54▼ −35.28%▼ −34.61%$1.80 (−67.09%)
Sep 22, 2026
5w ago
6-K
BEARISH ★ 6/10
$5.47 $3.54▲ +35.28%▲ +34.61%$1.80 (+67.09%)
Sep 16, 2026
5w ago
6-K
NEUTRAL ★ 4/10
$6.33 $5.47▼ −13.59%▼ −15.41%$1.80 (−71.56%)
Sep 16, 2026
5w ago
Press Release
NEUTRAL ★ 5/10
$6.33 $5.47▼ −13.59%▼ −15.41%$1.80 (−71.56%)
Aug 28, 2026
8w ago
Press Release
MIXED ★ 7/10
$6.61 $6.37▼ −3.71%▼ −3.56%$1.80 (−72.77%)
Aug 28, 2026
8w ago
6-K
BEARISH ★ 7/10
$6.58 $6.50▲ +1.22%▲ +1.32%$1.80 (+72.64%)
Aug 27, 2026
8w ago
424B4
MIXED ★ 7/10
$6.57 $6.50▼ −1.07%▼ −1.33%$1.80 (−72.60%)
Aug 26, 2026
8w ago
6-K
BEARISH ★ 7/10
$6.78 $6.48▲ +4.42%▲ +4.30%$1.80 (+73.45%)
Showing 10 of 16

US Market Status

Market Closed — Opens Thu (11h 53m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 22, 2026